1-3 of 3
Katelin C Jackson
Close
Sort by
Journal Articles

Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplant

Clinical Trials & Observations
Scott R. Solomon, Melhem Solh, Lawrence E. Morris, Jr., H. Kent Holland, Lizamarie Bachier-Rodriguez, Xu Zhang, Caitlin Guzowski, Katelin C Jackson, Stacey Brown, Asad Bashey
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5215–5224.
https://doi.org/10.1182/bloodadvances.2023010477
Published: 2023
Includes: Supplemental data
Journal Articles

Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamide

Clinical Trials & Observations
Scott R. Solomon, Michael T. Aubrey, Xu Zhang, Katelin C. Jackson, Lawrence E. Morris, H. Kent Holland, Melhem M. Solh, Asad Bashey
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5311–5321.
https://doi.org/10.1182/bloodadvances.2020003110
Published: 2020
Includes: Supplemental data
Journal Articles

Prospective phase 2 trial of ixazomib after nonmyeloablative haploidentical peripheral blood stem cell transplant

Clinical Trials & Observations
Scott R. Solomon, Melhem Solh, Xu Zhang, Stacey Brown, Katelin C. Jackson, H. Kent Holland, Lawrence E. Morris, Asad Bashey
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3669–3676.
https://doi.org/10.1182/bloodadvances.2020001958
Published: 2020
Includes: Supplemental data